Indian Pharma Market Registers 8.5% Growth In Dec 2020

Mumbai : The Indian Pharmaceutical Market (IPM) has registered a growth of 8.5 per cent for the month of December 2020, as against growth of one per cent in November 2020.

According to AIOCD AWACS report, the IPM has recorded sales of Rs. 1,45,354 crore for moving annual total (MAT) basis during December 2020.

Amongst the top 10 corporates, Cipla exhibited the highest growth of 8.9 per cent, followed by Torrent Pharma at 7.0 per cent.  Amongst the 11 to 25 ranked corporates, Glenmark Pharma exhibited highest growth of 16.3 per cent followed by Himalaya at 14.1 per cent.

Amongst the 26 to 50 ranked corporates, Apex Lab registered the highest growth of 20.1 per cent followed by Boehringer Ingelheim at 14.4 per cent. Amongst the 51 to 75 ranked corporates, Danone registered the highest growth of 33.5 per cent. Amongst the 76 to 100 ranked corporates, Reckitt Benckiser exhibited the highest growth at 23.6 per cent, followed by Llyod Hc at 14.4 per cent.

Some therapies continue the trend of revival in December 2020.Cardiac registered a monthly growth of 14.9% as compared to 8.7% in November 2020, while anti-diabetic registered growth of 9.9% in December 2020 as compared to 1.9% in November 2020.While respiratory medicines growth slumps to -8.7% in December 2020 as compared to -6.9 % in November 2020.

Post unlockdown since June 2020 the struggle for anti-infectives at 0.2% in November 2020 continues 5.2% in December 2020 and its associated therapy like gastro exhibits growth of 16.2% in December 2020 as against 3.1% in November 2020.

Vitamins have bounced back has growth of 14.0% in December 2020 as compared to 6.6 % in November 2020 and pain and analgesics are at  6.0% in December 2020 as against -5.2% in November 2020.

LEAVE A REPLY

Please enter your comment!
Please enter your name here